Creating a Paradigm for Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. Goeffrey Oxnard and Lauren Ritterhouse consider the advantages and disadvantages of liquid biopsies as an early screening tool for biomarker testing, and how to integrate various approaches into a biomarker testing paradigm.

August 15, 2013

The Evolving Role of Genotypic Data

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.

July 29, 2015

Advances in Personalized Medicine and Immuno-oncology

Dr. Steve O’Day discusses the current state of cancer treatments, which focuses less on standard chemotherapy and has begun relying more on targeted therapies and immune-oncology.